Navigation Links
SRI International Establishes Metabolite Standards Synthesis Center for National Heart, Lung and Blood Institute

MENLO PARK, Calif., Jan. 6, 2014 /PRNewswire/ -- SRI International has received a $4.5 million contract from the National Heart, Lung and Blood Institute, part of the National Institutes of Health, to establish a Metabolite Standards Synthesis Center to prepare molecules for researchers to use in the emerging field of metabolomics.

Like genomics and proteomics, which study the collective characterization and quantification of biological molecules in an organism, metabolomics is the study of all of the chemical reactions that take place in the body to sustain life. It's like taking a chemical snapshot of the physiology of a cell or entire body.

Enormous amounts of information can be gleaned from comprehensively characterizing thousands of the chemical byproducts of metabolism called metabolites. Metabolomics offers new ways for researchers to detect disease, monitor disease progression and response to therapy, stratify patients based on biochemical profiles, and identify new biomarkers and drug targets. A major roadblock in metabolomics research, however, is that researchers often do not have access to the metabolite standards they need to confirm and quantify their results.

"Currently, more than half of all human metabolites are unavailable, and many metabolites have never been synthesized or their structures have only been speculated, and therefore these important molecules are not available to researchers," said Mary Tanga, Ph.D., director of the Center for Chemical Biology in SRI Biosciences and principal investigator of SRI's Metabolite Standards Synthesis Center. "Researchers can pursue the answers to important questions if they actually have the compounds. The reference standards that SRI scientists will synthesize are critical to advances in metabolomics."

SRI's Metabolite Standards Synthesis Center will begin to fill the gap by creating a library of thousands of metabolites that will be made available to the scientific community. Synthesized metabolites function as standards for research and are critical for confirming the identity of previously unknown components in biological samples such as blood or urine. Studies of these small molecule metabolites will improve understanding of disease processes, reveal new biomarkers of disease, and provide new ways of monitoring therapeutic outcomes.

The SRI contract is part of a multicomponent program developed by the NIH Common Fund Metabolomics Program. The overall goal of the program is to increase metabolomics research capacity in the United States by supporting infrastructure expansion, training, technology development, and reference standards synthesis.

Requests for compound synthesis should be submitted to the Metabolomics Workbench. Upon NIH approval, SRI chemists will prepare sufficient material for the original requester and future projects.

About SRI Biosciences 

SRI Biosciences carries out basic research, drug discovery, and drug development. SRI has all of the resources necessary to take R&D from initial discoveries to clinical trials. SRI's product pipeline has yielded marketed drugs, therapeutics currently in human testing, and additional programs at earlier stages. SRI Biosciences offers a wide range of contract research organization (CRO) services, helping government and industry clients and partners advance drugs and other biomedical products toward commercialization. SRI is also working to create the next generation of technologies in areas such as diagnostics, drug delivery, medical devices, and systems biology.

About SRI International

Innovations from SRI International have created new industries, billions of dollars of marketplace value, and lasting benefits to society—touching our lives every day. SRI, a nonprofit research and development institute based in Silicon Valley, brings its innovations to the marketplace through technology licensing, new products, and spin-off ventures. Government and business clients come to SRI for pioneering R&D and solutions in computing and communications, chemistry and materials, education, energy, health and pharmaceuticals, national defense, robotics, sensing, and more.

Visit SRI's website and Timeline of Innovation to learn more about SRI.

This project has been funded in whole with Federal funds from the National, Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN268201300022C.

SOURCE SRI International
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
4. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
5. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
6. Chindex International, Inc. to Report First Quarter 2012 Financial Results
7. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
8. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
9. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
10. Bacterin International Signs Its Third National GPO Contract with Novation
11. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
Post Your Comments:
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center for ... Table in Battle Creek, MI, where the rehabilitation facility is located. This annual celebration ... world’s leading providers of cereal and other breakfast foods. Its residents often refer to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):